Oral composition
By blending a phosphocholine group-containing polymer with tranexamic acid and silica in oral compositions, the dispersibility and stability issues are resolved, maintaining a stable formulation with improved silica dispersibility.
Patent Information
- Application Number
- JP2017198057
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2017-10-11
- Publication Date
- 2024-12-04
- Estimated Expiration
- 2037-10-11
AI Technical Summary
Oral compositions containing tranexamic acid, silica, and water exhibit poor dispersibility due to variations in the balance of water absorption and blending amounts, leading to formulation instability and defects.
Incorporating a phosphocholine group-containing polymer with tranexamic acid, silica, and water, maintaining a predetermined total water absorption value, improves dispersibility and formulation stability.
The composition maintains good appearance during storage and enhances usability by preventing caking and syneresis, ensuring excellent dispersibility of silica.
Smart Images

Figure 0007594346000001 
Figure 0007594346000002 
Figure 0007594346000003
Abstract
Description
[Technical field]
[0001] The present invention relates to an oral composition having improved dispersibility, which contains tranexamic acid, its derivatives and salts thereof (hereinafter sometimes referred to as "tranexamic acids"), a phosphocholine group-containing polymer, silica blended to have a specified total water absorption value, and water. [Background technology]
[0002] Phosphocholine group-containing polymers such as 2-methacryloyloxyethyl phosphorylcholine-butyl methacrylate copolymers have high affinity for the living body and have been reported to have moisturizing properties, prevent the adhesion of microorganisms to the oral cavity, and prevent gingivitis, and are therefore used in oral compositions (see, for example, Patent Documents 1 to 3).
[0003] Tranexamic acid is known to have anti-hemorrhagic, anti-allergic, and anti-inflammatory effects due to its antiplasmin activity, and is used in oral compositions, for example, as a periodontal disease preventive agent (see, for example, Patent Document 4).
[0004] In addition, silica has a thickening effect and an abrasive effect, and is used in oral compositions similar to phosphocholine group-containing polymers and tranexamic acids. However, the formulation stability of oral compositions containing silica and water has not been sufficiently studied. [Prior art documents] [Patent documents]
[0005] [Patent Document 1] JP 2006-219450 A [Patent Document 2] JP 2011-153101 A [Patent Document 3] JP 2015-853 A [Patent Document 4] JP 2013-107837 A Summary of the Invention [Problem to be solved by the invention]
[0006] The present inventors have investigated the formulation stability of oral compositions containing tranexamic acids, silica, and water, and have encountered a new problem that poor dispersibility occurs depending on the balance between the water absorption amount of silica contained in the oral composition and its blending amount, resulting in a decrease in the formulation stability of the oral composition. That is, it has become clear that oral compositions containing tranexamic acids, silica, and water have a unique problem of poor dispersibility when the product of the water absorption amount (mL / g) and the content (wt%) of silica (hereinafter sometimes referred to as the total water absorption value) is blended within a certain range.
[0007] Therefore, an object of the present invention is to provide a formulation technology that can improve the dispersibility of an oral composition containing tranexamic acids, silica blended to achieve a specified total water absorption value, and water. [Means for solving the problem]
[0008] The present inventors have conducted extensive research to solve the above problems, and have found that an oral composition containing a phosphocholine group-containing polymer together with tranexamic acids, silica blended at a specific total water absorption value, and water has improved dispersibility. The present invention has been completed through further research based on this finding.
[0009] That is, the present invention provides the following aspects. Item 1. A composition comprising: (A) at least one selected from the group consisting of tranexamic acid, its derivatives, and salts thereof; (B) a phosphocholine group-containing polymer; (C) silica; and (D) water; A composition for an oral cavity, in which the product of the water absorption amount (mL / g) and the content (wt %) of the component (C) is 7.4 to 48. Item 2. The oral composition according to Item 1, wherein the component (B) is a 2-methacryloyloxyethyl phosphorylcholine / butyl methacrylate copolymer. Item 3. The oral composition according to Item 1 or 2, wherein the (B) component is contained in a total amount of 0.1 to 40 parts by weight per 100 parts by weight of the (C) component. Item 4. The oral composition according to any one of Items 1 to 3, wherein the component (C) contains thickening silica, and the content of the thickening silica is 2.5% by weight or more. Item 5. The oral composition according to any one of Items 1 to 3, wherein the component (C) contains abrasive silica, and the content of the abrasive silica is 5.5% by weight or more. Item 6. A dispersibility improver used to improve the dispersibility of component (C) in an oral composition comprising (A) at least one selected from the group consisting of tranexamic acid, its derivatives, and salts thereof, (C) silica, and (D) water, the product of the water absorption amount (mL / g) and the content (wt%) of component (C) being 7.4 to 48, (B) A dispersibility improver having a phosphocholine group-containing polymer as an active ingredient. Item 7. A method for improving dispersibility of a composition for an oral cavity comprising (A) at least one selected from the group consisting of tranexamic acid, its derivatives, and salts thereof, (C) silica, and (D) water, the product of the water absorption amount (mL / g) and the content (wt%) of the component (C) being 7.4 to 48, comprising: A method for improving dispersibility, comprising blending a phosphocholine group-containing polymer (B) together with the components (A), (C), and (D) into an oral composition. Effect of the Invention
[0010] According to the oral composition of the present invention, while containing tranexamic acids, silica blended to achieve a specified total water absorption value, and water, poor dispersibility of silica can be suppressed and the formulation has excellent stability, so that a formulation can be provided which can maintain a good appearance during storage and has an excellent feel in use. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0011] 1. Oral composition The oral composition of the present invention is characterized by containing at least one selected from the group consisting of tranexamic acids, i.e., tranexamic acid, its derivatives, and their salts (hereinafter, sometimes referred to as component (A)), a phosphocholine group-containing polymer (hereinafter, sometimes referred to as component (B)), (C) silica (hereinafter, sometimes referred to as component (C)), and water (hereinafter, sometimes referred to as component (D)). The oral composition of the present invention will be described in detail below.
[0012] (A) Tranexamic acids The oral composition of the present invention contains tranexamic acid, a derivative thereof and / or a salt thereof as component (A).
[0013] Tranexamic acid is a compound also known as trans-4-(aminomethyl)cyclohexanecarboxylic acid, and is a known drug known to have antihemorrhagic, antiallergic, anti-inflammatory, and other effects due to its antiplasmin action.
[0014] The derivatives of tranexamic acid are not particularly limited as long as they are pharma- ceutical or cosmetically acceptable, and specific examples thereof include tranexamic acid dimer, tranexamic acid ester, tranexamic acid vitamin ester, tranexamic acid alkylamide, tranexamic acid phenyl ester, and N,N-maleoylminotranexamic acid. Specific examples of tranexamic acid esters include alkyl esters having 1 to 30 carbon atoms; phenyl esters which may be substituted with alkyl groups having 1 to 30 carbon atoms, halogen atoms, carboxyl groups, etc. Specific examples of tranexamic acid alkylamides include tranexamic acid methylamide, tranexamic acid ethylamide, etc. These derivatives of tranexamic acid may be used alone or in combination of two or more.
[0015] The salt of tranexamic acid and / or its derivative is not particularly limited as long as it is pharma- ceutically or cosmetically acceptable, and specific examples thereof include inorganic acid salts such as hydrochloride, nitrate, sulfate, etc.; organic acid salts such as acetate, lactate, maleate, fumarate, tartrate, citrate, methanesulfonate, etc.; organic amine salts such as monoethanolamine salt, diethanolamine salt, triethanolamine salt, etc.; ammonium salt; alkali metal salts such as sodium salt, potassium salt, etc.; alkaline earth metal salts such as magnesium salt, etc. These salts may be used alone or in combination of two or more.
[0016] In the oral composition of the present invention, the component (A) may be one selected from tranexamic acid, salts of tranexamic acid, derivatives of tranexamic acid, and salts of derivatives of tranexamic acid, or two or more may be used in combination.
[0017] Of these components (A), from the standpoint of antihemorrhagic action, antiallergic action, anti-inflammatory action, etc., preferred is tranexamic acid or a salt thereof, more preferred is tranexamic acid.
[0018] In the oral composition of the present invention, the content of component (A) may be appropriately set depending on the medicinal effect to be provided by the oral composition, the formulation form of the oral composition, etc., and may be, for example, 0.001 to 0.5 wt %, preferably 0.005 to 0.1 wt %, more preferably 0.01 to 0.1 wt %, and even more preferably 0.05 to 0.1 wt %.
[0019] (B) Phosphocholine group-containing polymer The oral composition of the present invention contains a phosphocholine group-containing polymer as component (B). The phosphocholine group-containing polymer can improve the dispersibility of silica by being present together with component (A) and component (C) contained at a predetermined total water absorption value described below.
[0020] The phosphocholine group-containing polymer is a polymer formed by polymerizing a monomer containing a phosphocholine group (hereinafter, sometimes referred to as a "phosphocholine group-containing monomer"), and is a known component having moisturizing properties, etc.
[0021] In the phosphocholine group-containing polymer, the type of phosphocholine group-containing monomer is not particularly limited, and for example, a monomer having a phosphocholine group and a vinyl group can be mentioned. More specifically, the phosphocholine group-containing monomer can be 2-methacryloyloxyethyl phosphorylcholine, 2-methacryloyloxyethyl phosphorylethanolamine, etc. In the phosphocholine group-containing polymer, the phosphocholine group-containing monomer can be contained alone or in combination of two or more kinds. Among these phosphocholine group-containing monomers, 2-methacryloyloxyethyl phosphorylcholine is preferred from the viewpoint of further improving the effect of improving the dispersibility of silica.
[0022] The phosphocholine group-containing polymer used in the present invention may be a homopolymer consisting of one type of phosphocholine group-containing monomer, or a copolymer consisting of two or more types of monomers.
[0023] When the phosphocholine group-containing polymer is a copolymer, it may be a copolymer consisting of two or more types of phosphocholine group-containing monomers, or it may be a copolymer consisting of at least one type of phosphocholine group-containing monomer and at least one type of monomer other than the phosphocholine group-containing monomer.
[0024] The type of monomer other than the phosphocholine group-containing monomer contained in the phosphocholine group-containing polymer is not particularly limited, so long as it is pharma- ceutical acceptable and capable of radical polymerization with the phosphocholine group-containing monomer, and examples thereof include monomers having a vinyl group. Specific examples of monomers other than the phosphocholine group-containing monomer include alkyl (meth)acrylates such as methyl (meth)acrylate, ethyl (meth)acrylate, butyl (meth)acrylate, lauryl (meth)acrylate, stearyl (meth)acrylate, and 2-ethylhexyl (meth)acrylate; benzyl (meth)acrylate, phenoxyethyl (meth)acrylate, cyclohexyl (meth)acrylate, polypropylene glycol mono(meth)acrylate, polytetramethylene glycol mono(meth)acrylate, polypropylene glycol di(meth)acrylate, polytetramethylene glycol mono(meth)acrylate, polypropylene glycol polyethylene glycol mono(meth)acrylate, sodium methacrylate, and 2-hydroxy-3-methacryloyloxypropyltrimethylammonium. In the phosphocholine group-containing polymer, the monomers other than the phosphocholine group-containing monomer may be contained alone or in combination of two or more. Among these monomers other than the phosphocholine group-containing monomer, from the viewpoint of further improving the effect of improving the dispersibility of silica while effectively exerting the moisturizing effect, preferred are alkyl (meth)acrylates and 2-hydroxy-3-methacryloyloxypropyltrimethylammonium, more preferred are alkyl (meth)acrylates having an alkyl group with 1 to 18 carbon atoms, even more preferred are alkyl (meth)acrylates having an alkyl group with 3 to 5 carbon atoms, and particularly preferred are butyl (meth)acrylates. In this specification, "(meth)acrylate" refers to methacrylate and / or acrylate.
[0025] Specific examples of the phosphocholine group-containing polymer used in the present invention include polymethacryloyloxyethyl phosphorylcholine homopolymer, 2-methacryloyloxyethyl phosphorylcholine-butyl methacrylate copolymer (polyquaternium-51), 2-methacryloyloxyethylene phosphorylcholine-butyl methacrylate-sodium methacrylate copolymer (polyquaternium-65), 2-methacryloyloxyethyl phosphorylcholine-2-hydroxy-3-methacryloyloxypropyltrimethylammonium copolymer (polyquaternium-64), 2-methacryloyloxyethyl phosphorylcholine-stearyl methacrylate copolymer (polyquaternium-61), etc. In the above description of the phosphocholine group-containing polymer, the name in parentheses indicates the cosmetic ingredient name.
[0026] In the oral cavity composition of the present invention, one type of phosphocholine group-containing polymer may be used as component (B), or two or more types of phosphocholine group-containing polymers may be used in combination.
[0027] Among these (B) components, from the viewpoint of effectively exerting a moisturizing effect while further improving the effect of improving the dispersibility of silica, preferred are 2-methacryloyloxyethyl phosphorylcholine / butyl methacrylate copolymer, polymethacryloyloxyethyl phosphorylcholine homopolymer, and 2-methacryloyloxyethyl phosphorylcholine / 2-hydroxy-3-methacryloyloxypropyltrimethylammonium copolymer; more preferred are 2-methacryloyloxyethyl phosphorylcholine / butyl methacrylate copolymer, and 2-methacryloyloxyethyl phosphorylcholine / 2-hydroxy-3-methacryloyloxypropyltrimethylammonium copolymer; and particularly preferred are 2-methacryloyloxyethyl phosphorylcholine / butyl methacrylate copolymer.
[0028] In the oral cavity composition of the present invention, the content of component (B) is not particularly limited, but may be, for example, 0.05 to 1 wt% in total of component (B). From the viewpoint of further improving the effect of improving the dispersibility of silica while effectively exerting the moisturizing effect, the total amount of component (B) is preferably 0.05 to 0.5 wt%, more preferably 0.05 to 0.3 wt%, and even more preferably 0.05 to 0.25 wt%.
[0029] In the oral cavity composition of the present invention, the ratio of the (B) component to the (C) component is determined according to the content of the (B) component and the total water absorption value of the (C) component, but for example, the total amount of the (B) component is 0.1 to 40 parts by weight per 100 parts by weight of the (C) component. As the ratio of the (B) component to the (C) component, from the viewpoint of effectively exerting the moisturizing effect while further improving the effect of improving the dispersibility of silica, the total amount of the (B) component is preferably 0.1 to 20 parts by weight, more preferably 0.15 to 7.5 parts by weight, and even more preferably 0.16 to 6.25 parts by weight per 100 parts by weight of the (C) component.
[0030] (C) Silica Silica is synonymous with silicic anhydride or silicon dioxide. Silica is a known ingredient that has thickening and stain-removing properties.
[0031] In the oral composition of the present invention, component (C) is contained so that the product of the water absorption amount (mL / g) of silica and the content (wt%) in the oral composition (total water absorption value) is 7.4 to 48, preferably 8 to 40, more preferably 9 to 35, and most preferably 10 to 30. As component (C), silica of any water absorption amount can be blended in any amount as long as the total water absorption value is within the above-mentioned range.
[0032] In the present invention, the water absorption is defined by absorbing water instead of oil in accordance with JIS K5101-13-1 (measurement method for oil absorption), as described in "Water Absorption of Silica" in the Examples below.
[0033] Examples of the (C) component include thickening silica and abrasive silica. Thickening silica is a known component having a thickening action, and abrasive silica is a known component having a dirt removing action. Either thickening silica or abrasive silica may be used alone, or both may be used in combination. The water absorption of thickening silica is 1.6 mL / g or more from the viewpoint of shape retention, etc., for example, 1.6 to 5 mL / g, and preferably 2 to 4 mL / g. Abrasive silica refers to silica that has a smaller water absorption than thickening silica, and the water absorption is preferably 1.5 mL / g or less, for example, 0.2 to 1.5 mL / g, and more preferably 0.5 to 1.4 mL / g, from the viewpoint of dirt removing ability, etc.
[0034] In the oral composition of the present invention, the lower limit of the content of component (C) is not particularly limited as long as the total water absorption value is within a predetermined range, and from the viewpoint of shape retention and / or stain removability, etc., the total amount of component (C) is, for example, 2.5% by weight or more, preferably 3% by weight or more, and more preferably 4% by weight or more. Also, the upper limit of the content of component (C) is not particularly limited as long as the total water absorption value is within a predetermined range, and from the viewpoint of dispersibility, etc., the total amount of component (C) is, for example, 45% by weight or less, preferably 35% by weight or less, more preferably 30% by weight or less, and even more preferably 25% by weight or less.
[0035] When the oral composition of the present invention contains thickening silica as component (C), the content of thickening silica may be, from the standpoint of shape retention, etc., for example, 2.5% by weight or more, preferably 3% by weight or more, and more preferably 4% by weight or more, and from the standpoint of dispersibility, etc., for example, 20% by weight or less, preferably 15% by weight or less, and more preferably 10% by weight or less.
[0036] When the oral composition of the present invention contains abrasive silica as component (C), the content of the abrasive silica is, for example, 5.5% by weight or more, preferably 6% by weight or more, from the viewpoint of dirt removal property, and, for example, 30% by weight or less, preferably 20% by weight or less, more preferably 15% by weight or less, from the viewpoint of dispersibility, etc. The average particle size of the abrasive silica is, for example, 1 to 50 μm, preferably 2 to 20 μm. The average particle size is the 50% diameter (D) in the cumulative fraction based on volume in the particle size distribution measurement by the laser diffraction scattering method. 50 ).
[0037] In the oral cavity composition of the present invention, the ratio of component (C) to component (A) is determined depending on the respective contents of components (A) and (C), but may be, for example, 5 to 50,000 parts by weight of component (C) per part by weight of component (A). From the viewpoint of effectively exerting the effect of improving the dispersibility of silica while effectively exerting the antihemorrhagic action, antiallergic action, antiinflammatory action, etc. of tranexamic acids, the ratio of component (C) to component (A) is preferably 10 to 14,500 parts by weight, more preferably 30 to 7,000 parts by weight, and even more preferably 40 to 3,000 parts by weight of component (C) per part by weight of component (A).
[0038] (D)Water The oral composition of the present invention contains water as a base. When the above-mentioned (C) component is stored in the presence of tranexamic acids and water at a content that provides a predetermined total water absorption value, it tends to cause caking (formation of a deposit that is difficult to redisperse by shaking) and water syneresis due to poor dispersibility. However, the oral composition of the present invention can effectively improve the dispersibility of such silica to such an extent that neither caking nor water syneresis occurs.
[0039] In the oral composition of the present invention, the content of component (D) is appropriately set depending on the formulation form, etc., and can be, for example, 1 to 95% by weight, preferably 3 to 90% by weight, and more preferably 5 to 85% by weight.
[0040] Other Ingredients In addition to the above-mentioned components, the oral composition of the present invention may contain components that are commonly used in the art according to the formulation of the oral composition, within the scope that does not impair the effects of the present invention. Examples of such components include preservatives, bactericides, antibacterial agents, anti-inflammatory agents, abrasives, glucosyltransferase (GTase) inhibitors, plaque inhibitors, hypersensitivity inhibitors, tartar prevention agents, tooth strengthening / remineralization agents, antihistamines, local anesthetics, blood circulation promoters, thickeners, humectants, excipients, flavors, sweeteners, cooling agents, colorants, deodorants, surfactants, solvents, pH adjusters, etc.
[0041] Examples of preservatives, disinfectants, and antibacterial agents include hinokitiol, benzoic acids, salicylic acids, sorbic acids, parabens, dequalinium chloride, chlorhexidine chloride, chlorhexidine gluconate, isopropylmethylphenol, triclosan, lysozyme chloride, chlorhexidine hydrochloride, and potassium iodide.
[0042] The anti-inflammatory agent may be any component other than the above-mentioned component (A), and examples thereof include dipotassium glycyrrhizinate, glycyrrhetinic acid, methyl glycyrrhizinate, stearyl glycyrrhizinate, pyridoxine glycyrrhetinate, stearyl glycyrrhetinate, glyceryl glycyrrhetinate, glycyrrhetinic acid monoglucuronide, allantoin, epsilon aminocaproic acid, azulene, sodium chloride, vitamins, and the like.
[0043] Examples of the abrasive include hydrated silicic acid, aluminum oxide, aluminum hydroxide, calcium hydrogen phosphate, calcium phosphate, calcium pyrophosphate, calcium carbonate, crystalline cellulose, polyethylene powder, and charcoal particles.
[0044] Examples of GTase inhibitors include extracts of plants of the genus Oenothera in the Onagraceae family, extracts of plants of the genus Vitis in the Vitaceae family, dextranase, mutanase, tastein, tannins, ellagic acid, polyphenols, oolong tea extract, green tea extract, Swertia japonica, Chinese laurel, fennel, peony, gentiana, Senso, gentian, Coptis chinensis, and Coptis Rhizome.
[0045] Examples of plaque inhibitors include zinc citrate and gluconic acid.
[0046] Examples of the dentin hypersensitivity inhibitor include potassium nitrate and strontium chloride.
[0047] Anti-tartar agents include, for example, polyphosphates, zeolites, ethanehydroxydiphosphonate, and the like.
[0048] Examples of tooth strengthening / remineralizing agents include fluoride, sodium fluoride, sodium fluorophosphate, and stannous fluoride.
[0049] Antihistamines include, for example, diphenhydramine, diphenhydramine hydrochloride, and the like.
[0050] Examples of local anesthetics include procaine, tetracaine, bupivacaine, mepipacaine, chloroprocaine, proparacaine, meprylcaine or salts thereof, orthocaine, oxethazaine, oxypolyethyleneoxydecane, Scopolia extract, percaminepase, and tesitdesitin.
[0051] Examples of blood circulation promoters include vanillyl nonyl amide, nicotinic acid benzyl ester, capsaicin, and chili pepper extract.
[0052] Examples of thickening agents include polysaccharides such as pullulan, pullulan derivatives, and starch; hydroxypropyl cellulose, hydroxyethyl cellulose, hydroxypropyl methyl cellulose, hydroxyethyl methyl cellulose, carboxymethyl cellulose, carboxymethyl cellulose salts (sodium carboxymethyl cellulose, potassium carboxymethyl cellulose, etc.), methyl cellulose, ethyl cellulose, polyacrylic acid, polyacrylates (sodium polyacrylate, acrylic acid / octyl acrylate copolymer, etc.), copolymers of methacrylic acids (methacrylic acid and acrylic acid Examples of such polymeric substances include cellulose-based polymeric substances such as n-butyl polymers, polymers of methacrylic acid and methyl methacrylate, and polymers of methacrylic acid and ethyl acrylate; synthetic polymeric substances such as carboxyvinyl polymers, polyethylene glycol, polyvinyl alcohol, and polyvinylpyrrolidone; natural polymeric substances such as lectin, alginic acid, alginates (sodium alginate, potassium alginate, magnesium alginate, propylene glycol alginate, triethanolamine alginate, triisopropanolamine alginate, ammonium alginate, butylamine alginate, and diamylamine alginate), sodium chondroitin sulfate, agar, chitosan, and carrageenan; amino acid-based polymeric substances such as collagen and gelatin; and rubber-based polymeric substances such as gum arabic, karaya gum, tragacanth gum, xanthan gum, locust bean gum, guar gum, tamarind gum, and gellan gum.
[0053] Examples of humectants include glycerin, sorbitol, ethylene glycol, propylene glycol, polyethylene glycol, polypropylene glycol, xylitol, maltitol, lactol, and erythritol.
[0054] Examples of excipients include lactose, sucrose, mannitol, starch, dextrin, and crystalline cellulose.
[0055] Examples of the flavoring include natural flavorings (such as fennel oil), synthetic flavorings, and blends of these.
[0056] Examples of sweeteners include sodium saccharin, stevioside, stevia extract, aspartame, xylitol, starch syrup, honey, sorbitol, maltitol, mannitol, erythritol, and sugars (lactose, sucrose, fructose, glucose, etc.).
[0057] Examples of the cooling agent include menthol, erythritol, camphor, borneol, geraniol, and essential oils containing these.
[0058] The dyes include, for example, natural dyes, synthetic dyes, and mixtures thereof.
[0059] Examples of deodorants include zinc chloride, sodium copper chlorophyllin, coffee bean extract, burdock powder, green tea, roasted rice bran extract, and the like.
[0060] Examples of the surfactant include anionic surfactants such as polyoxyethylene lauryl ether sodium sulfate, sodium lauryl sulfate, sodium myristyl sulfate, sodium N-lauroyl sarcosinate, sodium N-myristyl sarcosinate, sodium dodecylbenzenesulfonate, hydrogenated coconut fatty acid monoglyceride sodium monosulfate, sodium lauryl sulfoacetate, sodium α-olefin sulfonate, sodium N-palmitoyl glutamate, and sodium N-methyl-N-acyltaurate; polyoxyethylene hydrogenated castor oil, sucrose fatty acid ester, maltose fatty acid ester, maltitol fatty acid ester, lactol fatty acid ester, sorbitan fatty acid ester, polyoxyethylene sorbitan monostearate, polyoxyethylene higher aryl fatty acid ester, polyoxyethylene ... Examples of the surfactants include nonionic surfactants such as cholester, polyoxyethylene polyoxypropylene copolymer, polyoxyethylene polyoxypropylene fatty acid ester, and polyglycerin fatty acid ester; amphoteric surfactants such as coconut oil fatty acid amidopropyl betaine, lauryl dimethylaminoacetate betaine, lauryl dimethylamine oxide, 2-alkyl-N-carboxymethyl-N-hydroxyethyl imidazolium betaine, N-lauryl diaminoethyl glycine, N-myristyl diaminoethyl glycine, and N-alkyl-1-hydroxyethyl imidazoline betaine sodium; and cationic surfactants such as lauryl trimethyl ammonium chloride, stearyl trimethyl ammonium chloride, benzethonium chloride, benzalkonium chloride, and stearyl dimethyl benzyl ammonium chloride.
[0061] Examples of the solvent include monohydric alcohols such as ethanol, propanol, butanol, pentanol, hexanol, and isopropanol.
[0062] Examples of pH adjusters include acetic acid, hydrochloric acid, sulfuric acid, nitric acid, citric acid, malic acid, lactic acid, phosphoric acid, benzoic acid, sodium hydroxide, potassium hydroxide, sodium acetate, sodium carbonate, sodium citrate, sodium hydrogen citrate, sodium lactate, calcium lactate, sodium phosphate, sodium hydrogen phosphate, and sodium benzoate.
[0063] When these components are contained in the oral cavity composition of the present invention, the content thereof may be appropriately set within the range generally used in the relevant technical field.
[0064] pH The pH of the oral composition of the present invention may be appropriately set within a range acceptable for application to the oral cavity, for example, 4 to 8, preferably 5 to 7.5, and more preferably 6 to 7. Here, the pH is a value measured under a temperature condition of 25°C.
[0065] Formulation The dosage form of the oral cavity composition of the present invention is not particularly limited as long as it can be applied to the oral cavity, and examples thereof include liquid and semi-solid forms (gel and paste).
[0066] The formulation of the oral composition of the present invention is not particularly limited as long as it can be applied to the oral cavity and remain there for a certain period of time, and examples thereof include oral hygiene agents such as liquid dentifrice, liquid dentifrice, toothpaste, mouthwash (liquid dentifrice and mouthwash are generally called mouth rinse, mouthwash, dental rinse, etc.), mouth fresheners (mouth spray, etc.), oral ointments, etc. Among these, preferred are liquid dentifrice, liquid dentifrice, toothpaste, and mouthwash, more preferred are liquid dentifrice, toothpaste, and mouthwash, and particularly preferred is toothpaste.
[0067] 2. Silica dispersibility improver and method for improving silica dispersibility As mentioned above, the phosphocholine group-containing polymer can improve the dispersibility of silica in the oral composition containing tranexamic acids, silica and water that are mixed at a predetermined total water absorption value.Therefore, the present invention further provides a dispersibility improver that is used to improve the dispersibility of silica in the oral composition containing tranexamic acids, silica and water that are mixed at a predetermined total water absorption value, and the dispersibility improver contains a phosphocholine group-containing polymer as an active ingredient.The present invention also provides a dispersibility improvement method that improves the dispersibility of silica in the oral composition containing tranexamic acids, silica and water that are mixed at a predetermined total water absorption value, and the dispersibility improvement method includes mixing the phosphocholine group-containing polymer with the oral composition together with tranexamic acids, silica and water that are mixed at a predetermined total water absorption value.
[0068] The dispersibility improver is used as an additive for a phosphocholine group-containing polymer, and the dispersibility improvement method is a method of utilizing a phosphocholine group-containing polymer to improve the dispersibility of silica in an oral composition containing tranexamic acids, silica formulated at a predetermined total water absorption value, and water.
[0069] In the dispersibility improving agent and the dispersibility improving method, the types and amounts of the components used, the form of the oral composition, etc. are as shown in the section "1. Oral composition" above. EXAMPLES
[0070] The present invention will be described in more detail below with reference to examples, but the present invention is not limited to these.
[0071] Test Example 1 Liquid preparations having the compositions shown in Tables 1 to 8 were prepared. Specifically, in the examples, tranexamic acid was added to purified water, stirred and dissolved, and then 2-methacryloyloxyethyl phosphorylcholine-butyl methacrylate copolymer was dissolved. Then, silica was added and mixed to obtain liquid preparations. In the comparative examples and reference examples, liquid preparations were obtained in the same manner, except that 2-methacryloyloxyethyl phosphorylcholine-butyl methacrylate copolymer was not used. 5 mL of the obtained liquid preparations were filled into a glass screw tube bottle (capacity 6 mL) and left to stand for 1 day at room temperature (25°C) under light-shielded conditions. The appearance of each liquid preparation after standing for 1 day was observed, and the degree of dispersion of silica was evaluated according to the following criteria.
[0072] <Criteria for determining the degree of silica dispersion> ○: After leaving it to stand for one day, when it was stirred by shaking it up and down vigorously 20 times, all of the silica was dispersed in the solution. ×: After leaving the mixture to stand for one day, when the mixture was stirred by vigorously shaking it up and down 20 times, some of the silica was not dispersed but adhered to the bottom of the container in an aggregated state (caking).
[0073] <Water absorption of silica> The water absorption (mL / g) for determining the total water absorption value of silica was defined as follows, with reference to JIS K5101-13-1 (measurement method for oil absorption). That is, 1 g of the measurement sample (silica) was placed on a glass plate, and purified water was gradually added 4 or 5 drops at a time, and each time, the purified water was kneaded into the sample with a palette knife; this was repeated, and the drop of purified water was continued until the sample became a lump; further, the work of dropping purified water one drop at a time into the lump and kneading it until it became uniform was repeated until the sample became a smooth paste (in this case, the paste state refers to a state in which there is no excess or deficiency of water, specifically, the sample spread on the glass plate with a palette knife does not crack, and further refers to the property that it can be reassembled into one lump with the palette knife); the amount of water (ml) required to make the sample into a paste was taken as the water absorption.
[0074] The results are shown in Tables 1 to 4. As shown in the tables, caking does not occur in the case of liquid preparations containing tranexamic acid and having a total water absorption value of silica less than 7.4 (Reference Examples 1 and 2), but caking occurs in the case of liquid preparations containing tranexamic acid and having a total water absorption value in the range of 7.4 to 48 (Comparative Examples 1 to 10). In contrast, caking was suppressed in the liquid preparations containing 2-methacryloyloxyethyl phosphorylcholine-butyl methacrylate copolymer (Examples 1 to 20). In other words, a good dispersion state of silica was maintained.
[0075] [Table 1]
[0076] [Table 2]
[0077] [Table 3]
[0078] [Table 4]
[0079] Test Example 2 In this test example, the degree of dispersion of silica was evaluated in the same manner as in Test Example 1, except that the thickening silica was changed to abrasive silica and liquid preparations having the compositions shown in Tables 5 to 8 were prepared.
[0080] The results are shown in Tables 5 to 8. As shown in the tables, caking does not occur in the case of liquid preparations containing tranexamic acid and having a total water absorption value of silica in the range of less than 7.4 (Reference Examples 3 and 4), but caking does occur in the case of liquid preparations containing tranexamic acid and having a total water absorption value in the range of 7.4 to 48 (Comparative Examples 11 to 22). In contrast, caking was suppressed in the liquid preparations containing 2-methacryloyloxyethyl phosphorylcholine-butyl methacrylate copolymer (Examples 21 to 44). In other words, the silica was able to maintain a good dispersion state.
[0081] [Table 5]
[0082] [Table 6]
[0083] [Table 7]
[0084] [Table 8]
[0085] Formulation Example 1 A toothpaste having the composition shown in Table 9 was prepared. The obtained toothpaste was stored in a tube container. The degree of dispersion of silica was evaluated according to the following criteria. In Table 9, the unit of the content of each component is weight percent.
[0086] <Criteria for determining the degree of silica dispersion> The toothpaste in a tube container was left to stand at 50°C for one month in the dark, and then the container was cut open and the release of water from the surface of the preparation was visually confirmed. ◎: No water release was observed or the surface was only slightly wet. ×: Syneresis was observed.
[0087] As shown in Table 9, in the obtained toothpaste, syneresis was suppressed and silica was well dispersed.
[0088] [Table 9]
[0089] Formulation Example 2 Toothpastes having the compositions shown in Table 10 were produced. The content of each component in the table is expressed in weight percent. The thickening silica and abrasive silica in the table were the same as those used in the above-mentioned Examples. Syneresis was suppressed after storage in all of the obtained toothpastes, indicating that the silica was well dispersed.
[0090] [Table 10]
Claims
1. (A) at least one member selected from the group consisting of tranexamic acid, tranexamic acid dimer, tranexamic acid alkyl (having 1 to 30 carbon atoms) ester, tranexamic acid vitamin ester, tranexamic acid alkylamide, tranexamic acid phenyl ester, N,N-maleoylminotranexamic acid, and salts thereof; (B) a phosphocholine group-containing polymer; (C) silica; and (D) water; The component (C) contains a thickening silica having a water absorption amount of 2 mL / g or more, and the content of the thickening silica is 4% by weight or more, An oral composition in which the product of the water absorption (mL / g) and the content (weight %) of the component (C) is 8 to 48 mL / g weight % (excluding, however, the cases where [i] sodium lauryl sulfate, sodium polyacrylate, xanthan gum, and an anti-inflammatory agent are contained, [ii] a fluorine compound and a polyphosphate are contained, and [iii] a dentifrice composition containing a fluorine-containing compound in an amount that results in a fluorine concentration of 1100 ppm to 3000 ppm).
2. A composition comprising: (A) at least one selected from the group consisting of tranexamic acid, tranexamic acid dimer, tranexamic acid alkyl (having 1 to 30 carbon atoms) ester, tranexamic acid vitamin ester, tranexamic acid alkylamide, tranexamic acid phenyl ester, N,N-maleoylminotranexamic acid, and salts thereof; (B) a phosphocholine group-containing polymer; (C) silica; and (D) water; the component (C) contains abrasive silica having a water absorption of 1.5 mL / g or less and thickening silica having a water absorption of 2 mL / g or more, the content of the abrasive silica is 5.5% by weight or more and the content of the thickening silica is 2.5% by weight or more, An oral composition in which the product of the water absorption (mL / g) and the content (weight %) of the component (C) is 7.4 to 48 mL / g weight % (excluding, however, the cases where [i] sodium lauryl sulfate, sodium polyacrylate, xanthan gum, and an anti-inflammatory agent are contained, [ii] a fluorine compound and a polyphosphate are contained, and [iii] a dentifrice composition containing a fluorine-containing compound in an amount that results in a fluorine concentration of 1100 ppm to 3000 ppm).
3. 3. The oral composition according to claim 1, wherein the component (B) is a 2-methacryloyloxyethyl phosphorylcholine / butyl methacrylate copolymer.
4. 4. The oral composition according to claim 1, wherein the total amount of the (B) component is 0.1 to 40 parts by weight per 100 parts by weight of the (C) component.
5. 2. The oral composition according to claim 1, wherein the component (C) contains abrasive silica having a water absorption of 1.5 mL / g or less, and the content of the abrasive silica is 5.5% by weight or more.
6. The present invention relates to a composition comprising: (A) at least one selected from the group consisting of tranexamic acid, tranexamic acid dimer, tranexamic acid alkyl (having 1 to 30 carbon atoms) ester, tranexamic acid vitamin ester, tranexamic acid alkylamide, tranexamic acid phenyl ester, N,N-maleoylminotranexamic acid, and salts thereof; (C) silica; and (D) water, wherein the component (C) contains a thickening silica having a water absorption of 2 mL / g or more, the content of the thickening silica is 4% by weight or more, and the absorption of the component (C) is 0.01 to 0.1 mL / g. A dispersibility improver used to improve the dispersibility of component (C) in an oral composition having a product of the amount of water (mL / g) and the content (wt%) of 8 to 48 mL / g wt% (excluding, however, the cases of [i] containing sodium lauryl sulfate, sodium polyacrylate, xanthan gum, and an anti-inflammatory agent, [ii] containing a fluorine compound and a polyphosphate, and [iii] a dentifrice composition containing a fluorine-containing compound in an amount resulting in a fluorine concentration of 1100 ppm to 3000 ppm), (B) A dispersibility improver having a phosphocholine group-containing polymer as an active ingredient.
7. A composition comprising (A) at least one selected from the group consisting of tranexamic acid, tranexamic acid dimer, tranexamic acid alkyl (having 1 to 30 carbon atoms) ester, tranexamic acid vitamin ester, tranexamic acid alkylamide, tranexamic acid phenyl ester, N,N-maleoylminotranexamic acid, and salts thereof, (C) silica, and (D) water, wherein the component (C) contains abrasive silica having a water absorption of 1.5 mL / g or less and thickening silica having a water absorption of 2 mL / g or more, the content of the abrasive silica being 5.5% by weight or more, and the content of the thickening silica being 5.5% by weight or more. 2.5% by weight or more, and the product of the water absorption (mL / g) and the content (wt%) of component (C) is 7.4 to 48 mL / g wt% (excluding, however, the cases of [i] sodium lauryl sulfate, sodium polyacrylate, xanthan gum, and an anti-inflammatory agent, [ii] a fluorine compound and a polyphosphate, and [iii] a dentifrice composition containing a fluorine-containing compound in an amount that results in a fluorine concentration of 1100 ppm to 3000 ppm), (B) A dispersibility improver having a phosphocholine group-containing polymer as an active ingredient.
8. (A) at least one selected from the group consisting of tranexamic acid, tranexamic acid dimer, tranexamic acid alkyl (having 1 to 30 carbon atoms) ester, tranexamic acid vitamin ester, tranexamic acid alkylamide, tranexamic acid phenyl ester, N,N-maleoylminotranexamic acid, and salts thereof; (C) silica; and (D) water, wherein the component (C) contains a thickening silica having a water absorption amount of 2 mL / g or more, and the content of the thickening silica is 4% by weight or more, and the component (C) A method for improving dispersibility of component (C) in an oral composition in which the product of the water absorption (mL / g) and the content (wt%) of the component is 8 to 48 mL / g wt% (excluding the cases where [i] the composition contains sodium lauryl sulfate, sodium polyacrylate, xanthan gum, and an anti-inflammatory agent, [ii] the composition contains a fluorine compound and a polyphosphate, and [iii] the composition is a dentifrice composition containing a fluorine-containing compound in an amount that results in a fluorine concentration of 1100 ppm to 3000 ppm), comprising: A method for improving dispersibility, comprising blending a phosphocholine group-containing polymer (B) together with the components (A), (C), and (D) into an oral composition.
9. A composition comprising (A) at least one selected from the group consisting of tranexamic acid, tranexamic acid dimer, tranexamic acid alkyl (carbon number 1 to 30) ester, tranexamic acid vitamin ester, tranexamic acid alkylamide, tranexamic acid phenyl ester, N,N-maleoylminotranexamic acid, and salts thereof, (C) silica, and (D) water, wherein the component (C) contains abrasive silica having a water absorption of 1.5 mL / g or less and thickening silica having a water absorption of 2 mL / g or more, the content of the abrasive silica being 5.5% by weight or more, and the thickening silica being 5.5% by weight or more. % or more by weight, and the product of the water absorption (mL / g) and the content (wt%) of component (C) is 7.4 to 48 mL / g by weight (excluding, however, the cases of [i] sodium lauryl sulfate, sodium polyacrylate, xanthan gum, and an anti-inflammatory agent, [ii] a fluorine compound and a polyphosphate, and [iii] a dentifrice composition containing a fluorine-containing compound in an amount that results in a fluorine concentration of 1100 ppm to 3000 ppm), comprising: A method for improving dispersibility, comprising blending a phosphocholine group-containing polymer (B) together with the components (A), (C), and (D) into an oral composition.
Citation Information
Patent Citations
Composition for use in oral cavity
JP1992139120A
Preparation of precipitated silica
JP1995149514A
Ink and its usage
JP2002249684A
Toothpaste composition
JP2003081799A
Skin care preparation
JP2006219450A
